Therapeutic potential of luteolin on cancer

M Çetinkaya, Y Baran - Vaccines, 2023 - mdpi.com
Cancer is a global concern, as the rate of incidence is increasing each year. The challenges
related to the current chemotherapy drugs, such as the concerns related to toxicity, turn to …

RAGE and its ligands: molecular interplay between glycation, inflammation, and hallmarks of cancer—a review

G Palanissami, SFD Paul - Hormones and Cancer, 2018 - Springer
Risk of cancer especially of colon, breast, and pancreas is high in diabetic and obese
patients, with potential involvement of augmented expression of RAGE (receptor for …

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

JML Ebos, CR Lee, JG Christensen… - Proceedings of the …, 2007 - National Acad Sciences
Cancer patients treated with antiangiogenic multitargeted receptor tyrosine kinase (RTK)
inhibitors show increased levels of plasma VEGF and placental growth factor and decreased …

Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis

C Chiodoni, MP Colombo, S Sangaletti - Cancer and Metastasis Reviews, 2010 - Springer
The family of matricellular proteins comprises molecules with disparate biology. The main
characteristic of matricellular proteins is to be expressed during tissue renewal and repair in …

Osteopontin promotes vascular endothelial growth factor–dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms

G Chakraborty, S Jain, GC Kundu - Cancer research, 2008 - AACR
Angiogenesis is the hallmark of cancer, and development of aggressiveness of primary
tumor depends on de novo angiogenesis. Here, using multiple in vitro and in vivo models …

Hepatocellualar carcinoma serum markers

G Bertino, A Ardiri, M Malaguarnera… - Seminars in …, 2012 - Elsevier
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some
areas of the world. In most cases, HCC is diagnosed at a late stage. Therefore, the …

Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis

R Raja, S Kale, D Thorat, G Soundararajan, K Lohite… - Oncogene, 2014 - nature.com
Hypoxia is a salient feature of most solid tumors, and hypoxic adaptation of cancer cells has
crucial implications in propagation of malignant clonal cell population. Osteopontin (OPN) …

Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer

SK Ramaiah, S Rittling - Toxicological sciences, 2008 - academic.oup.com
Osteopontin (OPN) is a highly modified integrin-binding extracellular matrix
glycophosphoprotein produced by cells of the immune system, epithelial tissue, smooth …

Osteopontin as a therapeutic target for cancer

M Bandopadhyay, A Bulbule, R Butti… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Cancer is a complex pathological disorder, established as a result of
accumulation of genetic and epigenetic changes, which lead to adverse alterations in the …

Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells

R Behera, V Kumar, K Lohite, S Karnik… - …, 2010 - academic.oup.com
Deregulation of signal transducer and activator of transcription (STAT)-3 signaling plays
crucial role in oncogenesis of various cancers. However, the molecular mechanism by which …